Cargando…

The Paradigm Change of IL-33 in Vascular Biology

In this review, we focus on the actual understanding of the role of IL-33 in vascular biology in the context of the historical development since the description of IL-33 as a member of IL-1 superfamily and the ligand for ST2 receptor in 2005. We summarize recent data on the biology, structure and si...

Descripción completa

Detalles Bibliográficos
Autores principales:	Demyanets, Svitlana, Stojkovic, Stefan, Huber, Kurt, Wojta, Johann
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8707059/ https://www.ncbi.nlm.nih.gov/pubmed/34948083 http://dx.doi.org/10.3390/ijms222413288

Ejemplares similares

Cardioprotective cytokine interleukin‐33 is up‐regulated by statins in human cardiac tissue
por: Pentz, Richard, et al.
Publicado: (2018)

Soluble ST2 in Patients with Carotid Artery Stenosis—Association with Plaque Morphology and Long-Term Outcome
por: Stojkovic, Stefan, et al.
Publicado: (2023)

An increase of interleukin-33 serum levels after coronary stent implantation is associated with coronary in-stent restenosis
por: Demyanets, Svitlana, et al.
Publicado: (2014)

Components of the interleukin-33/ST2 system are differentially expressed and regulated in human cardiac cells and in cells of the cardiac vasculature
por: Demyanets, Svitlana, et al.
Publicado: (2013)

Tissue factor is induced by interleukin-33 in human endothelial cells: a new link between coagulation and inflammation
por: Stojkovic, Stefan, et al.
Publicado: (2016)

Soluble ST2 and All-Cause Mortality in Patients with Chronic Obstructive Pulmonary Disease—A 10-Year Cohort Study
por: Urban, Matthias H., et al.
Publicado: (2021)

GDF‐15 is a better complimentary marker for risk stratification of arrhythmic death in non‐ischaemic, dilated cardiomyopathy than soluble ST2
por: Stojkovic, Stefan, et al.
Publicado: (2018)

Soluble ST2 as a Potential Biomarker for Abdominal Aortic Aneurysms—A Single-Center Retrospective Cohort Study
por: Klopf, Johannes, et al.
Publicado: (2022)

Soluble ST2 and Interleukin-33 Levels in Coronary Artery Disease: Relation to Disease Activity and Adverse Outcome
por: Demyanets, Svitlana, et al.
Publicado: (2014)

Plasma levels of interleukin-33 and soluble suppression of tumorigenicity 2 in patients with advanced pancreatic ductal adenocarcinoma undergoing systemic chemotherapy
por: Kieler, Markus, et al.
Publicado: (2018)

Association of Soluble Suppression of Tumorigenesis 2 (sST2) With Platelet Activation, Monocyte Tissue Factor and Ischemic Outcomes Following Angioplasty and Stenting
por: Stojkovic, Stefan, et al.
Publicado: (2020)

Surrogate Markers of Neutrophil Extracellular Trap Formation are Associated with Ischemic Outcomes and Platelet Activation after Peripheral Angioplasty and Stenting
por: Demyanets, Svitlana, et al.
Publicado: (2020)

PAI-1 (Plasminogen Activator Inhibitor-1) Expression Renders Alternatively Activated Human Macrophages Proteolytically Quiescent
por: Hohensinner, Philipp J., et al.
Publicado: (2017)

Changes of Circulating Extracellular Vesicles from the Liver after Roux-en-Y Bariatric Surgery
por: Rega-Kaun, Gersina, et al.
Publicado: (2019)

G-CSF Predicts Cardiovascular Events in Patients with Stable Coronary Artery Disease
por: Katsaros, Katharina M., et al.
Publicado: (2015)

The pro-inflammatory marker soluble suppression of tumorigenicity-2 (ST2) is reduced especially in diabetic morbidly obese patients undergoing bariatric surgery
por: Demyanets, Svitlana, et al.
Publicado: (2020)

Alternative activation of human macrophages enhances tissue factor expression and production of extracellular vesicles
por: Hohensinner, Philipp J., et al.
Publicado: (2020)

IL-33/IL-31 Axis in Osteoporosis
por: De Martinis, Massimo, et al.
Publicado: (2020)

IL-33 in Mental Disorders
por: Pandolfo, Gianluca, et al.
Publicado: (2021)

IL-33 and Airway Inflammation
por: Oboki, Keisuke, et al.
Publicado: (2011)

Longitudinal changes in the expression of IL-33 and IL-33 regulated genes in relapsing remitting MS
por: Sriram, Subramaniam, et al.
Publicado: (2018)

Neutrophil gelatinase associated lipocalin (NGAL) is elevated in type 2 diabetics with carotid artery stenosis and reduced under metformin treatment
por: Eilenberg, W., et al.
Publicado: (2017)

Proteomic Atlas of Atherosclerosis: The Contribution of Proteoglycans to Sex Differences, Plaque Phenotypes, and Outcomes
por: Theofilatos, Konstantinos, et al.
Publicado: (2023)

Role of IL-33 in inflammation and disease
por: Miller, Ashley M
Publicado: (2011)

Biomarkers Associated with Cardiovascular Disease in COVID-19
por: Kaufmann, Christoph C., et al.
Publicado: (2022)

The ST2/Interleukin-33 Axis in Hematologic Malignancies: The IL-33 Paradox
por: Allegra, Alessandro, et al.
Publicado: (2019)

The Role of IL-33 in Rheumatic Diseases
por: Duan, Lihua, et al.
Publicado: (2013)

IL-33/IL-31 Axis in Immune-Mediated and Allergic Diseases
por: Murdaca, Giuseppe, et al.
Publicado: (2019)

Emerging Effects of IL-33 on COVID-19
por: Gao, Yuan, et al.
Publicado: (2022)

Cytokines (interleukin-9, IL-17, IL-22, IL-25 and IL-33) and asthma
por: Farahani, Rahim, et al.
Publicado: (2014)

A complicated liaison: IL-33 and IL-33R in arthritis pathogenesis
por: Kamradt, Thomas, et al.
Publicado: (2013)

IL-33 and IL-37: A Possible Axis in Skin and Allergic Diseases
por: Borgia, Francesco, et al.
Publicado: (2022)

IL-33/IL-31 Axis: A Potential Inflammatory Pathway
por: Di Salvo, Eleonora, et al.
Publicado: (2018)

The Role of IL-33 in Gut Mucosal Inflammation
por: Pastorelli, Luca, et al.
Publicado: (2013)

The Role of IL-33 in Experimental Heart Transplantation
por: Chen, Jie, et al.
Publicado: (2020)

Interleukin-33 (IL-33) as a Diagnostic and Prognostic Factor in Traumatic Brain Injury
por: Erenler, Ali Kemal, et al.
Publicado: (2020)

The role of IL-33 and mast cells in allergy and inflammation
por: Saluja, Rohit, et al.
Publicado: (2015)

Role of the IL-33-ST2 axis in sepsis
por: Xu, Hui, et al.
Publicado: (2017)

The Role of IL-33/ST2 Pathway in Tumorigenesis
por: Larsen, Kristen M., et al.
Publicado: (2018)

The IL-33/ST2 Pathway in Cerebral Malaria
por: Glineur, Corine, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_9gt8rfu02dh0bdlj9d3ecn9edo